Proteome analysis of human androgen-independent prostate cancer cell lines: Variable metastatic potentials correlated with vimentin expression

被引:52
|
作者
Wu, Mingfu
Bai, Xiangyang
Xu, Gang
Wei, Juncheng
Zhu, Tao
Zhang, Yongtao
Li, Qiong
Liu, Ping
Song, Anping
Zhao, Liangpin
Gang, Chen
Han, Zhiqiang
Wang, Shixuan
Zhou, Jianfeng
Lu, Yunpin
Ma, Ding
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Res Ctr, Wuhan 430030, Hebei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan 430030, Hebei, Peoples R China
关键词
2-DE; androgen-independent prostate cancer; metastasis; vimentin;
D O I
10.1002/pmic.200600643
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To better understand the molecular mechanisms of prostate cancer (PCA) dissemination and to develop new anti-metastasis therapies, key regulatory molecules involved in PCA metastasis were identified in two human androgen-independent PCA cell lines, highly metastatic 1E8-H and lowly metastatic 2B4-L, cells. Through 2-DE and MS analyses, 12 proteins with different expression levels in the two cell lines were identified. The following proteins were found to be significantly up-regulated in 1E8-H cells compared with 2B4-L cells: gp96 precursor, calreticulin precursor, vimentin (VIM), Hsp90 alpha, peroxiredoxin 2, HNRPH1, ezrin, T-complex protein 1, alpha subunit, and hypothetical protein mln2339. In contrast, heart L-lactate dehydrogenase H chain, annexin I, and protein disulfide isomerase were notably down-regulated in 1E8-H cells compared with 2B4-L cells. To our knowledge, this study is the first to demonstrate that up-regulation of VIM expression positively correlates with the invasion and metastasis of androgen-independent PCA.
引用
收藏
页码:1973 / 1983
页数:11
相关论文
共 50 条
  • [1] Variable Metastatic Potentials Correlate with Differential Plectin and Vimentin Expression in Syngeneic Androgen Independent Prostate Cancer Cells
    Burch, Tanya C.
    Watson, Megan T.
    Nyalwidhe, Julius O.
    PLOS ONE, 2013, 8 (05):
  • [2] Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines
    Jongsma, J
    Oomen, MHA
    Noordzij, MA
    Romijn, JC
    van der Kwast, TH
    Schröder, FH
    van Steenbrugge, GJ
    PROSTATE, 2000, 42 (01): : 34 - 44
  • [3] Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines
    Dovio, Andrea
    Sartori, Maria Luisa
    De Francia, Silvia
    Mussino, Stefano
    Perotti, Paola
    Saba, Laura
    Abbadessa, Giuliana
    Racca, Silvia
    Angeli, Alberto
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 116 (1-2): : 29 - 36
  • [4] High molecular mass proteome of androgen-independent prostate cancer
    Kuruma, H
    Egawa, S
    Oh-Ishi, M
    Kodera, Y
    Satoh, M
    Chen, WG
    Okusa, H
    Matsumoto, K
    Maeda, T
    Baba, S
    PROTEOMICS, 2005, 5 (04) : 1097 - 1112
  • [5] Low PSA metastatic androgen-independent prostate cancer
    Sella, A
    Konichezky, M
    Flex, D
    Sulkes, A
    Baniel, J
    EUROPEAN UROLOGY, 2000, 38 (03) : 250 - 254
  • [6] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Beer, TM
    Garzotto, M
    Henner, WD
    Eilers, KM
    Wersinger, EM
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 968 - 970
  • [7] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    T M Beer
    M Garzotto
    W D Henner
    K M Eilers
    E M Wersinger
    British Journal of Cancer, 2003, 89 : 968 - 970
  • [8] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Bellmunt, Joaquim
    Albiol, Santiago
    Albanell, Joan
    BJU INTERNATIONAL, 2007, 100 (03) : 490 - 492
  • [9] Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines
    许克新
    王向红
    凌明达
    王云川
    中华医学杂志(英文版), 2003, (11) : 75 - 79
  • [10] Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines
    许克新
    王向红
    凌明达
    王云川
    ChineseMedicalJournal, 2003, (11)